September 17, 2017: Three New MASAC Documents

The National Hemophilia Foundation (NHF) recently announced that members of the Medical and Scientific Advisory Council (MASAC) gathered during NHF’s 69th Annual Meeting in Chicago on August 26, 2017. Three new documents related to treatment, therapies, women with bleeding disorders, carriers and emergency room management were created. These documents, which are listed below, were all adopted by NHF’s Board of Directors on September 17, 2017. The following links will direct you to each of the Documents, which are listed on the NHF Website. 

MASAC Document #250: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders.

MASAC Document #251: MASAC Guidelines for Perinatal Management of Women with Bleeding Disorders and Carriers of Hemophilia A and B.

MASAC Document #252: Guidelines for Emergency Department Management of Individuals with Hemophilia and Other Bleeding Disorders.

Click here to view the complete list of current MASAC documents. 

(Announcement adapted from a news announcement found here at https://www.hemophilia.org/Newsroom/Medical-News/MASAC-Issues-Three-New-Documents)

---